Published in Antimicrob Agents Chemother on June 01, 1998
Vibrio vulnificus in Taiwan. Emerg Infect Dis (2004) 1.25
In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother (2002) 1.07
Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis (2007) 1.06
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob Agents Chemother (2005) 0.94
Prognostic factor of mortality and its clinical implications in patients with necrotizing fasciitis caused by Vibrio vulnificus. Eur J Clin Microbiol Infect Dis (2014) 0.86
Vibrio Vulnificus Necrotizing Fasciitis Associated with Acupuncture. Infect Dis Rep (2015) 0.86
Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus. World J Surg (2010) 0.85
Vibrio vulnificus Septicemia After Handling Tilapia Species Fish: A Canadian Case Report and Review. Can J Infect Dis Med Microbiol (2006) 0.83
In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis. PLoS One (2014) 0.80
In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila. Antimicrob Agents Chemother (2001) 0.80
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrob Agents Chemother (2008) 0.79
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med (1988) 4.11
Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika (1951) 3.29
Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim. J Clin Microbiol (1980) 3.22
Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun (1978) 2.67
Acute bacterial myositis caused by Vibrio vulnificus. JAMA (1981) 2.42
Spectrum of Vibrio infections in a Gulf Coast community. Ann Intern Med (1983) 2.40
Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis (1992) 2.36
Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol (1991) 2.21
Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther (1983) 1.42
Antibiotic therapy for Vibrio vulnificus infection. JAMA (1985) 1.11
In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother (1997) 1.08
Vibrio vulnificus infection--report of 8 cases and review of cases in Taiwan. Changgeng Yi Xue Za Zhi (1994) 0.99
Mouse skin damage caused by a recombinant extracellular metalloprotease from Vibrio vulnificus and by V. vulnificus infection. J Formos Med Assoc (1997) 0.95
Vibrio vulnificus infection. Scand J Infect Dis (1989) 0.94
In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan. Eur J Clin Microbiol Infect Dis (1995) 0.88
[Septicemia and gangrenous change of the legs caused by marine vibrio, V. vulnificus--report of a case]. Taiwan Yi Xue Hui Za Zhi (1987) 0.84
Use of tetracycline for treatment of Vibrio vulnificus infections. Clin Infect Dis (1992) 0.84
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Neurologic complications in children with enterovirus 71 infection. N Engl J Med (1999) 5.22
Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother (2001) 4.72
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Structure and function of the multifunctional DNA-repair enzyme exonuclease III. Nature (1995) 3.00
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother (2000) 2.96
Separation of intermediates of the citric acid cycle and related compounds by thin-layer chromatography. Anal Biochem (1966) 2.81
Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol (1992) 2.72
alpha, beta-Dihydroxyisovalerate dehydratase. A superoxide-sensitive enzyme. J Biol Chem (1987) 2.61
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (1995) 2.48
PDFfit2 and PDFgui: computer programs for studying nanostructure in crystals. J Phys Condens Matter (2007) 2.45
Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2001) 2.21
Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12
Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol (2000) 2.11
High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother (1997) 1.97
Enhancement of phagocytosis by interferon-containing preparations. Infect Immun (1971) 1.97
Role of interferon in experimental mouse malaria. Nature (1968) 1.96
Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (1991) 1.95
Mosquitocidal toxins of bacilli and their genetic manipulation for effective biological control of mosquitoes. Microbiol Rev (1993) 1.88
Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan. J Clin Microbiol (2001) 1.88
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun (1998) 1.84
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer (2000) 1.79
Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis (1996) 1.77
Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest (1998) 1.74
PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int (2007) 1.73
Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett (1987) 1.69
Cell-specific transcriptional control of the mouse DNA-binding protein mC/EBP. Proc Natl Acad Sci U S A (1989) 1.66
Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy. N Engl J Med (1999) 1.64
Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect (2000) 1.61
Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection (2001) 1.60
Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun (1998) 1.54
Optimization of submerged culture requirements for the production of mycelial growth and exopolysaccharide by Cordyceps jiangxiensis JXPJ 0109. J Appl Microbiol (2004) 1.53
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Clin Exp Dermatol (2009) 1.53
Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum (1995) 1.52
Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol (2000) 1.51
Mutational dissociation of the positive and negative regulatory properties of the Spo0A sporulation transcription factor of Bacillus subtilis. Gene (1991) 1.44
Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol (2001) 1.42
A positive feedback loop controls transcription of the spoOF gene, a component of the sporulation phosphorelay in Bacillus subtilis. Mol Microbiol (1993) 1.42
Evolution of an organophosphate-degrading enzyme: a comparison of natural and directed evolution. Protein Eng (2003) 1.40
Scrub typhus associated with multiorgan failure: a case report. Scand J Infect Dis (1997) 1.39
Measurement error--"how much of a difference does it take to make a difference"? Fertil Steril (1997) 1.39
Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cell Mol Life Sci (2008) 1.37
Interferon induced by Plasmodium berghei. Science (1968) 1.34
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (1997) 1.34
Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res (1987) 1.34
Catalytic growth and characterization of gallium nitride nanowires. J Am Chem Soc (2001) 1.33
Arcobacter butzleri bacteremia in a patient with liver cirrhosis. J Formos Med Assoc (2000) 1.26
Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett (1983) 1.26
Regulation of IL-6 expression by oncostatin M. J Immunol (1991) 1.26
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc (1996) 1.25
Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J Exp Med (1980) 1.23
Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis (1998) 1.22
Methylobacterium mesophilicum synovitis in an alcoholic. Clin Infect Dis (1997) 1.19
Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan. J Clin Microbiol (2000) 1.16
A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol (1987) 1.16
A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci U S A (2000) 1.16
Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem J (1996) 1.15
Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol (1996) 1.15
Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis (1998) 1.15
Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis (1999) 1.13
Clinical, electrophysiological characteristics, and radiofrequency catheter ablation of atrial tachycardia near the apex of Koch's triangle. Pacing Clin Electrophysiol (1998) 1.12
Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010. Eur J Clin Microbiol Infect Dis (2011) 1.12
Incisional hernia after laparotomy: prospective randomized comparison between early-absorbable and late-absorbable suture materials. World J Surg (2000) 1.12
Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin Infect Dis (1995) 1.11
Regulation of transcription of the cell division gene ftsA during sporulation of Bacillus subtilis. J Bacteriol (1992) 1.10
Working memory of school-aged children with a history of febrile convulsions: a population study. Neurology (2001) 1.09
Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol (2001) 1.09
Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist (2001) 1.09
Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother (2000) 1.09
In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother (1997) 1.08
Snapping syndrome caused by the semitendinosus tendon. A case report. J Bone Joint Surg Am (1989) 1.07
Suppurative Acinetobacter baumanii thyroiditis with bacteremic pneumonia: case report and review. Clin Infect Dis (1998) 1.07
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J Formos Med Assoc (2000) 1.07
Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy (2008) 1.07
Interferon preparations enhance phagocytosis in vivo. Infect Immun (1976) 1.06
Comparison of the MB/BacT and BACTEC MGIT 960 system for recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis (2000) 1.06
Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells. Infect Immun (1999) 1.05
Risk factors for a first febrile convulsion in children: a population study in southern Taiwan. Epilepsia (1999) 1.05
Avulsion of the pectoralis major tendon. Am J Sports Med (1992) 1.04
Protein tyrosine kinases: structure, substrate specificity, and drug discovery. Biopolymers (1998) 1.04